Nuveen Q1 2026 Preview: A $381.9B Giant Added Credit and Bond ETFs Without Abandoning AI
Nuveen’s Q4 2025 filing stayed large-cap and AI-heavy at the top, but the more revealing addition was a sizable fixed-income sleeve through NXUS and NHYB. The next filing will show whether those credit and bond ETFs remain central or fade back out.
Nuveen, LLC closed Q4 2025 with one of the largest disclosed books in the market and one of the clearest two-layer structures. The equity core still belonged to NVDA, MSFT, AAPL, and AMZN. But the new fixed-income sleeve, led by NXUS and NHYB, was large enough to change how the filing should be read. That makes Nuveen an important watchlist going into May 15, 2026.
TL;DR
- The top still looked like the AI era: NVDA and MSFT remained enormous.
- But the new bond sleeve was too big to ignore: NXUS and NHYB arrived immediately at meaningful size.
- This was not a defensive exit: Nuveen still added to select growth names such as NFLX.
- The portfolio looked balanced, not split-brained: credit exposure sat beside the equity winners rather than replacing them.
- Q1 watch: does Nuveen keep both layers, or was the fixed-income sleeve temporary?
Nuveen, LLC Top Holdings — 2025Q4 ($M)
Why This Filing Matters
Nuveen matters because it shows how a very large platform can layer macro ballast into a still-pro-risk equity portfolio. A filing that keeps NVDA and MSFT huge while also introducing NXUS and NHYB is effectively saying the manager wanted both participation and protection.
Visible Signals In The Latest Filing
| Position | Value | Weight | Why it matters |
|---|---|---|---|
| NVDA | $25.33B | 7.31% | Nvidia stayed the biggest disclosed position and kept Nuveen exposed to the market’s main leadership theme. |
| MSFT | $23.29B | 6.72% | Microsoft remained another pillar of the equity core. |
| NXUS | $2.54B | 0.73% | NXUS was a very large new position and immediately changed the portfolio’s visible asset mix. |
| NHYB | $1.61B | 0.46% | NHYB reinforced that the new fixed-income sleeve was intentional, not incidental. |
| NFLX | $1.93B | 0.56% | Netflix was also one of the biggest relative stock increases under the hood. |
Nuveen, LLC Top 5 vs Rest Concentration — 2025Q4
What Q4 2025 Set Up
That is what makes the next update important. If the fixed-income sleeve remains in place, the Q4 filing becomes a much clearer macro statement. If it fades out while the AI core stays large, the moves will look more tactical than structural.
Nuveen, LLC AUM History
Questions For Q1 2026
Do the bond ETFs stay large?
If NXUS and NHYB remain prominent, Nuveen’s fixed-income sleeve should be treated as a real strategic overlay.
Can the equity leaders still dominate?
If NVDA and MSFT stay on top, the fund still wants strong participation in the market’s main growth winners.
Was Netflix a side bet or a new theme?
If NFLX keeps gaining, it will show the equity side of the filing is broadening even while fixed income becomes more visible.
Bottom Line
Nuveen’s next filing matters because Q4 2025 looked like a deliberate balance between AI leadership and fixed-income ballast. If both layers survive, readers should treat the fund as a clean example of how large allocators are trying to stay invested without becoming one-way risk books.
Q&A
When is Nuveen’s next 13F due?
Nuveen’s next 13F is due on May 15, 2026.
What was the biggest change in Q4 2025?
The addition of large NXUS and NHYB positions was the biggest structural change.
Why does that matter?
Because it changes the filing from a pure equity-growth story into a broader asset-allocation story.
Related Research
Explore all researchFisher’s Q4 2025 filing was still packed with mega-cap tech, but the bigger tell was a giant Treasury and investment-grade corporate bond sleeve built through IEF and VCIT. The next filing will show whether that duration bet was tactical or structural.
Apr 17, 2026
Victory Capital kept mega-cap tech on top in Q4 2025, but the sharper signal was in the secondary moves: large increases in Netflix, Constellation Energy, TSMC and new positions like IQVIA. The next filing will show whether that diversification continues.
Apr 17, 2026
AQR’s Q4 2025 filing kept expanding, with AUM rising to $190.63B, 69 new names, and a dramatic Bristol Myers build inside an already broad book. The next filing will show whether the quant giant keeps pressing this expansion or starts normalizing the roster again.
Apr 17, 2026
Principal’s Q4 2025 filing looked slightly weaker on headline AUM, but the internal rotation was more revealing: Brookfield became a top-ten position, Netflix surged, and the fund cut back in parts of real estate. The next filing will show whether that shift keeps going.
Apr 17, 2026
Janus Henderson kept Nvidia and Microsoft on top in Q4 2025, but the more interesting signal was underneath: new exposure to Intuitive Surgical, Protagonist Therapeutics and other growth-healthcare names. The next filing will show whether that rotation keeps building.
Apr 17, 2026